MSI-H/MMRd 和 MSS/pMMR
我们是谁
Fc 工程抗 CTLA-4 单克隆抗体博腾西单抗在晚期癌症中的应用
对 NCI 外科处免疫疗法临床研究协议的评估
Neo-T in Treating Patients With Advanced Solid Tumors(GI-NeoT-03)
个性化 TCR-T:经收养性转移的 T 细胞受体基因工程 T 细胞 (TCR-T) 研究
Disitamab Vedotin Combined With Tislelizumab in Advanced HER2 Positive Colorectal Cancer
评估 GDC-1971 与阿特珠单抗联合治疗局部晚期或转移性实体瘤患者的安全性、药代动力学和活性的研究
A Safety and Antitumor Activity Trial of Immunoradiotherapy Combinations as a Treatment Option for Subjects With Metastatic Solid Tumors
An Expanded Clinical Study of Triple Therapy for Refractory Solid Tumors That Failed First-line Treatment for Recurrence and Metastasis
治疗转移性结直肠癌患者的 GCC19CART
索托拉西布和帕尼单抗与研究者选择治疗克氏鼠肉瘤(KRAS)p.G12C 突变患者(代码 300)